Bayer MaterialScience examines feasibility of 400,000-ton MDI plant in Europe
Total worldwide capacity would increase to 1,850,000 tons a year
It is intended that the new world-scale facility should incorporate, for the first time, a new, highly energy-efficient technology for the final stage in the reaction, that of phosgenation. Thanks to this process innovation the energy consumption of the plant can be decreased considerably by reducing the solvent cycles. Consequently, the emissions per unit of manufacturing will also be significantly reduced. Furthermore, the specific investment costs are expected to be clearly lower than for a conventional plant of the same size.
The new facility is intended to form part of a complete, newly designed MDI train that will also include production plants for the precursors nitrobenzene, aniline and diphenylmethane diamine (MDA). The train would be the largest and most modern integrated MDI production facility in Europe.
Other news from the department manufacturing
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.